Top compounds associated with response to SREK1


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC 0.02 0.6
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA etomoxir CTRPv2 pan-cancer AAC 0.021 0.6
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.02 0.6
mRNA AT-406 CTRPv2 pan-cancer AAC 0.026 0.6
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA masitinib GDSC1000 pan-cancer AAC 0.018 0.6
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.02 0.6
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.019 0.6
Download CSV